The Pharmacy and Poisons Board (PPB) warns of falsified Phesgo. [PPB]
The Pharmacy and Poisons Board (PPB) has issued a public health alert after identifying a falsified batch of a cancer medication circulating in the Kenyan pharmaceutical market.
PPB warns that the breast cancer drug poses a serious risk to patient safety and public health.
In a statement, the regulator Acting PPB Chief Executive Officer Dr Ahmed Mohamed said the counterfeit product is labeled as Phesgo (Pertuzumab/Trastuzumab) 600mg/600mg in 10ml, Batch Number C5290S20, but does not match any authentic manufacturer records.
The agency raised alarm over significant discrepancies between the fake product and the genuine formulation, noting that the falsified version contains a white powder instead of a liquid solution.
